8-K: Strive Completes Semler Scientific Acquisition, Boosts Bitcoin Holdings
Merger Completion and Corporate Update
Strive, Inc. has successfully acquired Semler Scientific, significantly increasing its Bitcoin treasury to 12,797.9 BTC and appointing new leadership to drive strategic growth.
Summary
- Strive, Inc. completed the acquisition of Semler Scientific, Inc. on January 16, 2026, making Semler Scientific a wholly-owned subsidiary of Strive.
- Each outstanding share of Semler Scientific common stock was converted into 21.05 shares of Strive Class A common stock.
- The conversion right for Semler Scientific's 4.25% Convertible Senior Notes due 2030 (with $100 million aggregate principal outstanding) now allows conversion into Strive Class A common stock, with an adjusted initial conversion rate of 275.3887 shares of Strive Common Stock per $1,000 principal amount of Notes.
- Strive, Inc. has guaranteed Semler Scientific's outstanding 4.25% Convertible Senior Notes due 2030.
- Strive's Bitcoin treasury now holds approximately 12,797.9 bitcoins as of January 16, 2025, positioning it as the #11 largest public corporate holder globally.
- Avik Roy resigned from Strive's Board of Directors to assume the role of Chief Strategy Officer, focusing on monetizing Semler Scientific's operating business by expanding early disease detection products.
- Eric Semler, former Executive Chairman of Semler Scientific, was appointed as an independent Class II director to Strive's Board.
- Joe Burnett, previously Director of Bitcoin Strategy for Semler Scientific, joined Strive as VP of Bitcoin Strategy.
- Strive's stockholders approved the 2026 Omnibus Equity Incentive Plan, which authorizes an initial grant of 110,789,280 shares of Strive Common Stock, plus annual automatic increases.
Sentiment
Score: 8
Explanation: The filing announces the successful completion of a strategic acquisition, significantly increasing Bitcoin holdings and strengthening management with key appointments. The new equity incentive plan is positive for employee motivation. While standard risks are noted, the overall tone and content reflect successful execution of strategic initiatives.
Positives
- Completion of the Semler Scientific acquisition expands Strive's strategic footprint.
- Strive's Bitcoin holdings significantly increased to approximately 12,797.9 BTC, making it a top global corporate holder.
- Appointment of Avik Roy as Chief Strategy Officer brings expertise in biotech and strategic growth, with a focus on monetizing Semler Scientific's early disease detection products.
- Eric Semler's appointment to the board adds deep expertise in capital allocation, digital assets, and the Bitcoin industry.
- Joe Burnett's appointment as VP of Bitcoin Strategy strengthens Strive's focus on its Bitcoin treasury strategy.
- The 2026 Omnibus Equity Incentive Plan is designed to motivate and reward key personnel, aligning their interests with Strive's success.
- Strive Asset Management, a subsidiary, manages over $2 billion in assets, indicating strong operational performance in asset management.
Negatives
- No explicit negatives are stated in the filing; the tone is generally positive regarding the merger and strategic direction.
Risks
- Uncertainties related to market conditions and the completion of the offering on anticipated terms or at all.
- Outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
- Possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized as expected or at all.
- Risks associated with the implementation of Bitcoin treasury strategies and general market conditions for Bitcoin and other digital assets.
- Potential for the integration of the two companies to be more difficult, time-consuming, or costly than expected.
- Diversion of management's attention from ongoing business operations and opportunities.
- Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the transaction.
- Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the transaction.
- Changes in Strive's or Semler Scientific's share price before closing.
- Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.
Future Outlook
Strive intends to monetize Semler Scientific's operating business by expanding its mandate in early disease detection products. The company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. Strive Asset Management, a subsidiary, continues to manage over $2 billion in assets.
Management Comments
- Avik Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.
- Eric Semler's deep expertise in capital allocation, digital assets, and knowledge of the Bitcoin industry, corporate governance, strategic planning, and investment management qualify him to sit on the Strive Board.
- The general purpose of the 2026 Omnibus Equity Incentive Plan is to motivate and reward employees, consultants, advisors, other service providers, and non-employee directors who are expected to contribute significantly to Strive's success to perform at the highest level and to further Strive's best interests and those of Strive's stockholders.
Industry Context
This acquisition positions Strive as a significant player at the intersection of asset management, corporate Bitcoin treasury strategy, and healthcare technology. By acquiring Semler Scientific, which was noted as the 'second U.S. public company to adopt Bitcoin as its primary treasury reserve asset,' Strive reinforces its stated mission as the 'first publicly traded asset management Bitcoin treasury company.' The strategic move to expand Semler Scientific's early disease detection products under Avik Roy's leadership suggests a dual focus on both digital asset growth and leveraging existing healthcare operational strengths. This aligns with a broader trend of companies exploring alternative treasury assets like Bitcoin while also pursuing core business expansion.
Comparison to Industry Standards
- Bitcoin Holdings: Strive now holds approximately 12,797.9 bitcoins, making it the #11 largest public corporate holder of Bitcoin globally. This places it among a select group of companies like MicroStrategy and Tesla that have adopted Bitcoin as a significant treasury reserve asset.
- Asset Management: Strive Asset Management, LLC manages over $2 billion in assets, which is a substantial figure for an asset management firm, indicating a competitive position within the industry.
- Healthcare Technology (QuantaFlo): Semler Scientific's QuantaFlo product, an FDA-cleared device for peripheral arterial disease detection, operates in the medical device and diagnostic sector. While no direct comparable companies or specific project results are detailed in the filing for a direct benchmark, its FDA clearance is a standard regulatory achievement for medical devices.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Strategy Officer | NA | Avik Roy | 2026-01-16 | Resigned from Board to join company in a full-time executive capacity. |
| Class II Director (Strive Board) | Avik Roy | Eric Semler | 2026-01-16 | Appointed to fill vacancy left by Mr. Roy's resignation, in accordance with Merger Agreement terms. |
| Audit Committee Member (Strive Board) | Avik Roy | Jonathan F. Macey | 2026-01-16 | Appointed to fill vacancy resulting from Mr. Roy's resignation. |
| Compensation Committee Member (Strive Board) | Avik Roy | James A. Lavish | 2026-01-16 | Appointed to fill vacancy resulting from Mr. Roy's resignation. |
| Nominating and Corporate Governance Committee Member (Strive Board) | Avik Roy | Mahesh Ramakrishnan | 2026-01-16 | Appointed to fill vacancy resulting from Mr. Roy's resignation. |
| VP of Bitcoin Strategy | NA | Joe Burnett | 2026-01-16 | Joined Strive from Semler Scientific following the acquisition. |
| Class I Director (Strive Board) | NA | Mahesh Ramakrishnan | NA (pending Information Statement mailing) | Elected by written consent of Majority Stockholders for a three-year term. |
| Class I Director (Strive Board) | NA | Jonathan R. Macey | NA (pending Information Statement mailing) | Elected by written consent of Majority Stockholders for a three-year term. |
| Class I Director (Strive Board) | NA | James Alexander Lavish | NA (pending Information Statement mailing) | Elected by written consent of Majority Stockholders for a three-year term. |
| Class II Director (Strive Board) | NA | Shirish Jajodia | NA (pending Information Statement mailing) | Ratified and confirmed by written consent of Majority Stockholders. |
| Class II Director (Strive Board) | NA | Eric Semler | NA (pending Information Statement mailing) | Ratified and confirmed by written consent of Majority Stockholders. |
| Class II Director (Strive Board) | NA | Pierre Rochard | NA (pending Information Statement mailing) | Ratified and confirmed by written consent of Majority Stockholders. |
| Class III Director (Strive Board) | NA | Matthew Cole | NA (pending Information Statement mailing) | Ratified and confirmed by written consent of Majority Stockholders. |
| Class III Director (Strive Board) | NA | Arshia Sarkhani | NA (pending Information Statement mailing) | Ratified and confirmed by written consent of Majority Stockholders. |
| Class III Director (Strive Board) | NA | Brian Logan Beirne | NA (pending Information Statement mailing) | Ratified and confirmed by written consent of Majority Stockholders. |
| Class III Director (Strive Board) | NA | Benjamin Bartley Pham | NA (pending Information Statement mailing) | Ratified and confirmed by written consent of Majority Stockholders. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- No specific legal proceedings are mentioned as current issues. The 'Cautionary Statement' mentions 'the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company' as a forward-looking risk, but not as an existing proceeding.
Related Party Transactions
- No specific related party transactions are disclosed beyond the merger itself and the subsequent appointments of former Semler Scientific executives/directors to Strive roles.
Stakeholder Impact
- Shareholders (Strive): Potential for long-term value creation through increased Bitcoin holdings and strategic expansion of the healthcare business. Dilution risk from issuance of Class A common stock for the merger and the new equity incentive plan.
- Shareholders (Semler Scientific): Received 21.05 shares of Strive Common Stock for each Semler share, effectively becoming Strive shareholders.
- Noteholders (Semler Scientific): Their convertible notes are now guaranteed by Strive and convertible into Strive Common Stock, potentially enhancing security and liquidity.
- Employees (Semler Scientific & Strive): Integration risks, but also new opportunities with Avik Roy's strategic focus and the new equity incentive plan. Joe Burnett's move to Strive indicates continuity in Bitcoin strategy.
- Customers (Semler Scientific): The focus on expanding early disease detection products suggests continued and potentially enhanced service offerings.
Next Steps
- Strive plans to file an Information Statement on Schedule 14C with the SEC regarding the matters approved by Majority Stockholders.
- The definitive Information Statement will be mailed to Strive's stockholders.
- The election of Class I directors, ratification of Class II and Class III directors, and approval of the 2026 Omnibus Equity Incentive Plan will become effective 20 days from the mailing date of the definitive Information Statement.
- Avik Roy's initial focus as Chief Strategy Officer will be on monetizing Semler Scientific's operating business by expanding its mandate in early disease detection products.
Key Dates
| Date | Description |
|---|---|
| 2025-01-23 | Date of the Purchase Agreement between Semler Scientific and Cantor Fitzgerald & Co. for the initial offering of Notes. |
| 2025-01-28 | Date of the original Indenture between Semler Scientific and U.S. Bank Trust Company, National Association, for the 4.25% Convertible Senior Notes due 2030. |
| 2025-08-01 | First Interest Payment Date for the 4.25% Convertible Senior Notes due 2030. |
| 2025-09-22 | Date of the original Agreement and Plan of Merger between Strive, Strive Merger Sub, Inc., and Semler Scientific, Inc. |
| 2025-12-03 | Date of Amendment No. 1 to Strive's Form S-4 filing with the SEC, including a letter agreement amending the Merger Agreement. |
| 2026-01-16 | Date of earliest event reported; completion of the merger of Strive Merger Sub, Inc. into Semler Scientific, Inc., making Semler Scientific a wholly-owned subsidiary of Strive. |
| 2026-01-16 | Date of the Supplemental Indenture to the 4.25% Convertible Senior Notes due 2030, reflecting the merger and Strive's guarantee. |
| 2026-01-16 | Effective date of Avik Roy's resignation from Strive's Board of Directors and appointment as Chief Strategy Officer. |
| 2026-01-16 | Effective date of Eric Semler's appointment to Strive's Board of Directors. |
| 2026-01-16 | Date Strive issued a press release announcing the completion of the Merger. |
| 2028-08-04 | Earliest date Semler Scientific may redeem the 4.25% Convertible Senior Notes due 2030. |
| 2030-05-01 | Date on or after which holders of the 4.25% Convertible Senior Notes due 2030 may convert their notes at any time, regardless of other circumstances. |
| 2030-08-01 | Maturity Date for the 4.25% Convertible Senior Notes due 2030. |
Recommendation
strong buyThe completion of the Semler Scientific acquisition is a significant strategic move, immediately boosting Strive's Bitcoin treasury to a top-tier global position. This aligns with Strive's stated mission to be a leading Bitcoin treasury company, which is a strong positive for investors bullish on Bitcoin. The appointment of Avik Roy as Chief Strategy Officer, with a clear mandate to expand Semler Scientific's operating business in early disease detection, demonstrates a dual growth strategy beyond just Bitcoin. Eric Semler and Joe Burnett's additions further strengthen the leadership's expertise in digital assets and strategic execution. While dilution from the merger and the new equity plan is noted, the strategic benefits, increased asset base, and clear growth initiatives make this a compelling 'strong buy' for investors seeking exposure to both Bitcoin and a growing healthcare technology business.
Keywords
Strive Inc., Semler Scientific, Merger, Acquisition, Bitcoin, Digital Assets, Convertible Notes, Corporate Governance, Executive Appointments, Equity Incentive Plan, Financial Reporting, SEC Filing, ASST, SMLR, QuantaFlo, Peripheral Arterial Disease
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.